Vasopressin during uncontrolled hemorrhagic shock: less bleeding below the diaphragm, more perfusion above.
Stadlbauer
Karl H
KH
Department of Anesthesiology and Critical Care Medicine, Innsbruck Medical University, Innsbruck, Austria.
Wenzel
Volker
V
Krismer
Anette C
AC
Voelckel
Wolfgang G
WG
Lindner
Karl H
KH
D002395:Catecholamines / Q000627:therapeutic use; D003964:Diaphragm / Q000098:blood supply / Q000502:physiology; D006470:Hemorrhage / Q000188:drug therapy* / Q000503:physiopathology; D006801:Humans; D010477:Perfusion; D012039:Regional Blood Flow / Q000502:physiology; D012771:Shock, Hemorrhagic / Q000188:drug therapy* / Q000503:physiopathology; D014662:Vasoconstrictor Agents / Q000009:adverse effects / Q000627:therapeutic use*; D014667:Vasopressins / Q000009:adverse effects / Q000627:therapeutic use*; D014947:Wounds and Injuries / Q000150:complications / Q000628:therapy
D002395:Catecholamines; D014662:Vasoconstrictor Agents; D014667:Vasopressins